US 8,545,493 B2Grant

Flow rate monitor for fluid cooled microwave ablation probe

Issue Date:2013-10-01

•10 Claims

•6 Drawing Sheets

Abstract

A microwave ablation system includes a generator operable to output energy and an ablation probe coupled to the generator that delivers the energy to a tissue region. The ablation system also includes a controller operable to control the generator and at least one sensor coupled to the ablation probe and the controller that detects an operating parameter of the ablation probe. The controller performs a system check by ramping up an energy output of the generator from a low energy level to a high energy level and monitors an output from the sensor at predetermined intervals of time during the system check to determine an abnormal state. The controller controls the generator to cease the energy output when the controller determines an abnormal state.

Metadata

Assignee

Covidien LP

Inventors

Joseph D. Brannan
Darion Peterson
Kenlyn S. Bonn
Richard A. Willyard

Application Information

Application Number:US 12/569,685

Filing Date:2009-09-29

Priority Date:2009-09-29

Art Unit:3739

Classifications

IPC:

A61B18/18

Patent Drawings (6 sheets)

Description

Cross-Reference to Related Applications

[0001] This patent application is related to copending patent application Ser. No. 12/562,575 filed Sep. 18, 2009 and entitled “METHOD FOR CHECKING HIGH POWER MWA SYSTEM STATUS ON STARTUP”, copending patent application Ser. No. 12/566,299 filed Sep. 24, 2009 and entitled “OPTICAL DETECTION OF INTERRUPTED FLUID FLOW TO MWA ANTENNA”, copending patent application Ser. No. 12/568,972 filed Sep. 29, 2009 and entitled “FLOW RATE MONITOR FOR FLUID COOLED MICROWAVE ABLATION PROBE” and copending patent application Ser. No. 12/569,171 filed Sep. 29, 2009 and entitled “FLOW RATE MONITOR FOR FLUID COOLED MICROWAVE ABLATION PROBE”.

Background

[0002] 1. Technical Field

[0003] The present disclosure relates generally to microwave ablation procedures that utilize microwave surgical devices having a microwave antenna which may be inserted directly into tissue for diagnosis and treatment of diseases. More particularly, the present disclosure is directed to a system and method for verifying correct system operation of a microwave ablation system.

[0004] 2. Background of Related Art

[0005] In the treatment of diseases such as cancer, certain types of cancer cells have been found to denature at elevated temperatures (which are slightly lower than temperatures normally injurious to healthy cells.) These types of treatments, known generally as hyperthermia therapy, typically utilize electromagnetic radiation to heat diseased cells to temperatures above 41° C., while maintaining adjacent healthy cells at lower temperatures where irreversible cell destruction will not occur. Other procedures utilizing electromagnetic radiation to heat tissue also include ablation and coagulation of the tissue. Such microwave ablation procedures, e.g., such as those performed for menorrhagia, are typically done to ablate and coagulate the targeted tissue to denature or kill the tissue. Many procedures and types of devices utilizing electromagnetic radiation therapy are known in the art. Such microwave therapy is typically used in the treatment of tissue and organs such as the prostate, heart, liver, lung, kidney, and breast.

[0006] One non-invasive procedure generally involves the treatment of tissue (e.g., a tumor) underlying the skin via the use of microwave energy. The microwave energy is able to non-invasively penetrate the skin to reach the underlying tissue. However, this non-invasive procedure may result in the unwanted heating of healthy tissue. Thus, the non-invasive use of microwave energy requires a great deal of control.

[0007] Presently, there are several types of microwave probes in use, e.g., monopole, dipole, and helical. One type is a monopole antenna probe, which consists of a single, elongated microwave conductor exposed at the end of the probe. The probe is typically surrounded by a dielectric sleeve. The second type of microwave probe commonly used is a dipole antenna, which consists of a coaxial construction having an inner conductor and an outer conductor with a dielectric junction separating a portion of the inner conductor. The inner conductor may be coupled to a portion corresponding to a first dipole radiating portion, and a portion of the outer conductor may be coupled to a second dipole radiating portion. The dipole radiating portions may be configured such that one radiating portion is located proximally of the dielectric junction, and the other portion is located distally of the dielectric junction. In the monopole and dipole antenna probes, microwave energy generally radiates perpendicularly from the axis of the conductor.

[0008] The typical microwave antenna has a long, thin inner conductor that extends along the axis of the probe and is surrounded by a dielectric material and is further surrounded by an outer conductor around the dielectric material such that the outer conductor also extends along the axis of the probe. In another variation of the probe that provides for effective outward radiation of energy or heating, a portion or portions of the outer conductor can be selectively removed. This type of construction is typically referred to as a “leaky waveguide” or “leaky coaxial” antenna. Another variation on the microwave probe involves having the tip formed in a uniform spiral pattern, such as a helix, to provide the necessary configuration for effective radiation. This variation can be used to direct energy in a particular direction, e.g., perpendicular to the axis, in a forward direction (i.e., towards the distal end of the antenna), or combinations thereof.

[0009] Invasive procedures and devices have been developed in which a microwave antenna probe may be either inserted directly into a point of treatment via a normal body orifice or percutaneously inserted. Such invasive procedures and devices potentially provide better temperature control of the tissue being treated. Because of the small difference between the temperature required for denaturing malignant cells and the temperature injurious to healthy cells, a known heating pattern and predictable temperature control is important so that heating is confined to the tissue to be treated. For instance, hyperthermia treatment at the threshold temperature of about 41.5° C. generally has little effect on most malignant growth of cells. However, at slightly elevated temperatures above the approximate range of 43° C. to 45° C., thermal damage to most types of normal cells is routinely observed. Accordingly, great care must be taken not to exceed these temperatures in healthy tissue.

[0010] In the case of tissue ablation, a high radio frequency electrical current in the range of about 500 MHz to about 10 GHz is applied to a targeted tissue site to create an ablation volume, which may have a particular size and shape. Ablation volume is correlated to antenna design, antenna performance, antenna impedance and tissue impedance. The particular type of tissue ablation procedure may dictate a particular ablation volume in order to achieve a desired surgical outcome. By way of example, and without limitation, a spinal ablation procedure may call for a longer, narrower ablation volume, whereas in a prostate ablation procedure, a more spherical ablation volume may be required.

[0011] Microwave ablation devices utilize sensors to determine if the system is working properly. However, without delivery of microwave energy, the sensors may indicate that the probe assembly status is normal. Further, defects in antenna assemblies may not be apparent except at high powers. As such, when microwave ablation system is tested using a low power routine, a post manufacture defect may not be apparent. This is especially important for high power microwave ablation devices, where failures may result in extremely high temperatures and flying debris.

[0012] Fluid cooled or dielectrically buffered microwave ablation devices may also be used in ablation procedures to cool the microwave ablation probe. Cooling the ablation probe may enhance the overall ablation pattern of antenna, prevent damage to the antenna and prevent harm to the clinician or patient. However, during operation of the microwave ablation device, if the flow of coolant or buffering fluid is interrupted, the microwave ablation device may exhibit rapid failures due to the heat generated from the increased reflected power.

Summary

[0013] The present disclosure provides a microwave ablation system. The microwave ablation system includes a generator operable to output energy, an ablation probe coupled to the generator that is operable to deliver the energy to a tissue region, a controller operable to control the generator, and at least one or more sensors coupled to the ablation probe and the controller. The sensor detects an operating parameter of the ablation probe. The controller performs a system check by ramping up an energy output of the generator from a low energy level to a high energy level and monitors an output from the at least one sensor at predetermined intervals of time during the system check to determine an abnormal state. The controller controls the generator to cease the energy output when the controller determines an abnormal state.

[0014] In embodiments, the sensor detects a temperature of the ablation probe, radiating behavior of the ablation probe, fluid pressure, forward and reflective power and fluid flow of coolant.

[0015] In yet another embodiment of the microwave ablation system, the sensor is a thermocouple, thermistor, optical fiber, receiving antenna, rectenna, radio frequency power sensor, pressure sensor resistive junction or capacitive junction.

[0016] The present disclosure also provides a method of detecting an abnormal state in a microwave ablation system. The method includes the steps of outputting a low energy level from a generator to an ablation probe and detecting an operational parameter of the ablation probe at the low energy level. The detected operational parameter is compared to a predetermined range for the operational parameter and an energy level output of the generator is increased in response to the comparison. The microwave ablation system ceases output of energy from the generator in response to the detected operational parameter being outside the predetermined range.

[0017] In embodiments, the operational parameter is a temperature of the ablation probe, radiating behavior of the ablation probe, fluid pressure, forward and reflective power, coolant flow in the probe and insertion depth of probe.

Brief Description of the Drawings

[0018] The above and other aspects, features, and advantages of the present disclosure will become more apparent in light of the following detailed description when taken in conjunction with the accompanying drawings in which:

[0019] FIG. 1 shows a representative diagram of a variation of a microwave antenna assembly in accordance with an embodiment of the present disclosure;

[0020] FIGS. 2A-2C show graphs of time versus power in accordance with embodiments of the present disclosure;

[0021] FIG. 3 shows a system block diagram according to an embodiment of the present disclosure;

[0022] FIG. 4 shows a system block diagram according to another embodiment of the present disclosure; and

[0023] FIG. 5 shows a flow chart describing a ramping procedure according to an embodiment of the present disclosure.

Detailed Description

[0024] Particular embodiments of the present disclosure are described hereinbelow with reference to the accompanying drawings; however, it is to be understood that the disclosed embodiments are merely exemplary of the disclosure and may be embodied in various forms. Well-known functions or constructions are not described in detail to avoid obscuring the present disclosure in unnecessary detail. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a basis for the claims and as a representative basis for teaching one skilled in the art to variously employ the present disclosure in virtually any appropriately detailed structure.

[0025] Like reference numerals may refer to similar or identical elements throughout the description of the figures. As shown in the drawings and described throughout the following description, as is traditional when referring to relative positioning on a surgical instrument, the term “proximal” refers to the end of the apparatus which is closer to the user and the term “distal” refers to the end of the apparatus which is further away from the user. The term “clinician” refers to any medical professional (i.e., doctor, surgeon, nurse, or the like) performing a medical procedure involving the use of embodiments described herein.

[0026] Electromagnetic energy is generally classified by increasing energy or decreasing wavelength into radio waves, microwaves, infrared, visible light, ultraviolet, X-rays and gamma-rays. As used herein, the term “microwave” generally refers to electromagnetic waves in the frequency range of 300 megahertz (MHz) (3×10⁸cycles/second) to 300 gigahertz (GHz) (3×10¹¹cycles/second). As used herein, the term “RF” generally refers to electromagnetic waves having a lower frequency than microwaves. The phrase “ablation procedure” generally refers to any ablation procedure, such as RF or microwave ablation or microwave ablation-assisted resection. The phrase “transmission line” generally refers to any transmission medium that can be used for the propagation of signals from one point to another.

[0027] FIG. 1 shows a microwave antenna assembly 100 in accordance with one embodiment of the present disclosure. Antenna assembly 100 includes a radiating portion 12 that is connected by feedline 110 (or shaft) via cable 15 to connector 16, which may further connect the assembly 100 to a power generating source 28, e.g., a microwave or RF electrosurgical generator. Assembly 100, as shown, is a dipole microwave antenna assembly, but other antenna assemblies, e.g., monopole or leaky wave antenna assemblies, may also utilize the principles set forth herein. Distal radiating portion 105 of radiating portion 12 includes a tapered end 120 that terminates at a tip 123 to allow for insertion into tissue with minimal resistance. It is to be understood, however, that tapered end 120 may include other shapes, such as without limitation, a tip 123 that is rounded, flat, square, hexagonal, cylindroconical or any other polygonal shape.

[0028] An insulating puck 130 is disposed between distal radiating portion 105 and proximal radiating portion 140. Puck 130 may be formed from any suitable elastomeric or ceramic dielectric material by any suitable process. In some embodiments, the puck 130 is formed by overmolding from polyether block amide (e.g., Pebax® sold by Arkema), polyetherimide (e.g., Ultem® and/or Extern® sold by SABIC Innovative Plastics), polyimide-based polymer (e.g., Vespel® sold by DuPont), or ceramic.

[0029] FIG. 2A is a graph depicting an operation of the microwave ablation system according to an embodiment of the invention. As depicted in FIG. 2A, at t=0, the energy output from the generator is 0 W. As t increases, the energy output also increases at a constant slope Δ. Slope Δ is sufficient to prevent any harm to a clinician or patient and to prevent and damage to the system. When t=ramp, with ramp being a value of time sufficient to determine if the microwave ablation system is malfunctioning, the energy output increases to an energy level, e.g., 140 W, sufficient to perform a microwave ablation procedure. During the ramping procedure (0<t<ramp), the microwave ablation system performs a system check to determine if the system is in proper working order or if the system is malfunctioning. If the system is malfunctioning, an energy output from the generator is ceased thereby preventing any harm to a clinician or patient or preventing any further damage to the microwave ablation system.

[0030] Alternatively, as shown in FIGS. 2B and 2C, a series of pulses may be used during the start up procedure. As shown in FIG. 2B, the series of pulses have a constant amplitude with a pulse width t_W. A duty cycle for the pulses may be varied in order to adequately check the system without harming the patient or the clinician. Alternatively, as shown in FIG. 2C, the series of pulses during the start up procedure may have a pulse width T_Wand vary in amplitude. The amplitude of the pulses may gradually reach an energy level sufficient to perform a microwave ablation procedure.

[0031] By utilizing a system check that gradually subjects the device to increasing operational stresses (while monitoring sensor status) will allow for microwave ablation systems to limit the number of devices that are damaged due to operator error, such as not turning on the cooling fluid pump. It will also reduce the likelihood of patient and/or user injury from potentially defective assemblies or from user error.

[0032] With reference to FIG. 3, a microwave ablation system, shown generally as 600, according to an embodiment of the disclosure is depicted. System 600 has an antenna assembly 610 that imparts microwave energy to a patient. Antenna assembly 610 is similar to antenna assembly 100 described above or antenna assembly may be a choked wet tip (CWT) antenna because the antenna performance needs cooling for power and tissue matching. Generator 620, which is substantially similar to power generating source 28, is coupled to antenna assembly 610 and provides a source of energy thereto. Controller 630 is coupled to generator 620 and is configured to control generator 620 based on an input or signal from sensor 640. Controller 630 may be a microprocessor or any logic circuit able to receive an input or signal from sensor 640 and provide an output to control generator 620. Sensor 640 may be a thermocouple, thermistor, optical fiber, receiving antenna, rectenna, radio frequency power sensor, pressure sensor resistive junction or capacitive junction. Sensor 640 may be a single sensor or an array of sensors to detect operational parameters of the antenna assembly 610 in order to determine if the microwave ablation system 600 is functioning properly. If the sensor 640 detects an abnormal value or level, the controller 630 controls the generator 620 to cease an energy output. Sensor 640 may be incorporated into antenna assembly 610 or controller 630 or may be coupled to either antenna assembly 610 and/or controller 630. Microwave ablation system 600 may also be incorporated in antenna assembly 610 or may be arranged in two or more devices. For instance, controller 630 and generator 620 may be incorporated in a single device or may be separate devices.

[0033] Sensor 640 may be a temperature sensor to detect the temperature of the antenna assembly 610. Temperature sensor may be a thermocouple, thermistor or an optical fiber. A thermocouple is a junction between two different metals that produces a voltage related to a temperature difference. Thermocouples are can also be used to convert heat into electric power. Any circuit made of dissimilar metals will produce a temperature-related difference of voltage. Thermocouples for practical measurement of temperature are made of specific alloys, which in combination have a predictable and repeatable relationship between temperature and voltage. Different alloys are used for different temperature ranges and to resist corrosion. Where the measurement point is far from the measuring instrument, the intermediate connection can be made by extension wires, which are less costly than the materials used to make the sensor. Thermocouples are standardized against a reference temperature of 0 degrees Celsius. Electronic instruments can also compensate for the varying characteristics of the thermocouple to improve the precision and accuracy of measurements.

[0034] A thermistor is a type of resistor whose resistance varies with temperature. Thermistors are widely used as inrush current limiters, temperature sensors, self-resetting overcurrent protectors, and self-regulating heating elements. The material used in a thermistor is generally a ceramic or polymer. Thermistors typically achieve a high precision temperature response within a limited temperature range.

[0035] Sensor 640 may also be used to monitor radiating behavior, e.g., a receiving antenna or a rectenna. The receiving antenna receives radiation from the antenna assembly and provides an electrical signal to indicate the level of radiation. A rectenna is a rectifying antenna, a special type of antenna that is used to directly convert microwave energy into DC electricity. Its elements are usually arranged in a multi-element phased array with a mesh pattern reflector element to make it directional. A simple rectenna can be constructed from a Schottky diode placed between antenna dipoles. The diode rectifies the current induced in the antenna by the microwaves.

[0036] Sensor 640 may also be an RF power sensor that monitors forward and reflected power. The RE power sensor measures the power output of the generator 620 that is utilized by the antenna assembly 610. It can also measure reflected power which is RF energy that is reflected from the ablated tissue region and received by the antenna assembly.

[0037] Sensor 640 may also be a pressure sensor for monitoring fluid and/or gas pressure. Pressure sensor generates a signal related to the pressure imposed. Typically, such a signal is electrical, but optical, visual, and auditory signals are also contemplated. Pressure sensors can be classified in terms of pressure ranges they measure, temperature ranges of operation, and most importantly the type of pressure they measure. In terms of pressure type, pressure sensors can be divided into five categories. Absolute pressure sensors which measure the pressure relative to perfect vacuum pressure (0 PSI or no pressure). Gauge pressure sensors may be used in different applications because it can be calibrated to measure the pressure relative to a given atmospheric pressure at a given location. Vacuum pressure sensors are used to measure pressure less than the atmospheric pressure at a given location. Differential pressure sensors measure the difference between two or more pressures introduced as inputs to the sensing unit. Differential pressure sensors may also be used to measure flow or level in pressurized vessels. Sealed pressure sensors are similar to the gauge pressure sensors except that it is previously calibrated by manufacturers to measure pressure relative to sea level pressure.

[0038] With reference to FIG. 4, a microwave ablation system, shown generally as 700, according to an embodiment of the present disclosure is depicted. Microwave ablation system 700 may be similar to ablation systems described above with regard to FIGS. 1 and 3. The system 700 includes an ablation device 702 having an antenna 702a and a handle 702b used to ablate tissue. Generator 706 supplies the ablation device with energy via coaxial cable 704. Ablation device 702 is supplied with coolant or buffering fluid from coolant supply 710 through conduit 708. The coolant flows through the ablation device 702 as described above and exits the ablation device 702 via conduit 708 into chamber 714. Conduit 708 may be a multi lumen conduit having an inflow lumen for supplying the ablation device 702 with coolant and an outflow lumen for coolant to exit the ablation device 702 into the chamber 714. Additionally, conduit 708 may be provided as two separate conduits, an inflow conduit and an outflow conduit.

[0039] As shown in FIG. 4, a sensor 712 is provided to monitor the flow rate through conduit 708. As described above, when coolant circulation is interrupted, the ablation device 702 may tend to exhibit rapid failures. By monitoring the fluid flow, damage to the ablation device 702 as well as harm to the clinician or patient can be prevented. Sensor 712 provides an electrical signal to the controller 716 that represents a real-time fluid flow measurement or pressure measurement. Controller 716 compares the electrical signal to a predetermined range. If the electrical signal is within a predetermined range, the controller 716 signals the generator 706 to continue with the ablation procedure. If the electrical signal is outside the predetermined range, the controller 716 controls the generator 706 to cease the ablation procedure. Sensor 712 may be placed anywhere along the fluid path. For instance, sensor 712 may be placed in antenna 702a, handle 702b or along the inflow lumen/conduit or outflow lumen/conduit. The sampling rate of sensor 712 should be sufficient enough to catch intermittent problems with the flow of fluid through the ablation system 700. Sensor 712 may be configured to detect the fluid flow during startup before microwave energy is delivered to the ablation device or during an ablation procedure.

[0040] Sensor 712 may be a pressure sensor similar to the pressure sensor described above with regard to FIG. 3. The pressure sensor measures the fluid pressure of the coolant or dielectric buffer and provides an electrical signal to the controller 716.

[0041] In some embodiments, sensor 712 may also be a fluid flow meter. There are many different types of fluid flow meters that can be used to measure the flow rate. In a differential pressure flow meter, the flow is calculated by measuring the pressure drop over an obstructions inserted in the flow. The differential pressure flowmeter is based on the Bernoulli's Equation, where the pressure drop and the further measured signal is a function of the square of the flow speed. In a velocity flowmeter the flow is calculated by measuring the speed in one or more points in the flow, and integrating the flow speed over the flow area. In a calorimetric flowmeter, two temperature sensors in close contact with the fluid but thermally insulated from each other are used. One of the two sensors is constantly heated and the cooling effect of the flowing fluid is used to monitor the flowrate. In a stationary (no flow) fluid condition there is a constant temperature difference between the two temperature sensors. When the fluid flow increases, heat energy is drawn from the heated sensor and the temperature difference between the sensors is reduced. The reduction is proportional to the flow rate of the fluid. Response times will vary due the thermal conductivity of the fluid. In general lower thermal conductivity require higher velocity for proper measurement. The calorimetric flowmeter can achieve relatively high accuracy at low flow rates.

[0042] An electromagnetic flowmeter operates on Faraday's law of electromagnetic induction that states that a voltage will be induced when a conductor moves through a magnetic field. The liquid serves as the conductor and the magnetic field is created by energized coils outside the flow tube. The voltage produced is directly proportional to the flow rate. Two electrodes mounted in the pipe wall detect the voltage that is measured by a secondary element. Electromagnetic flowmeters can measure difficult and corrosive liquids and slurries, and they can measure flow in both directions with equal accuracy. Electromagnetic flowmeters have a relatively high power consumption and can only be used for electrical conductive fluids such as water.

[0043] Ultrasonic flow meters measure the difference of the transit time of ultrasonic pulses propagating in and against flow direction. This time difference is a measure for the average velocity of the fluid along the path of the ultrasonic beam. By using the absolute transit times both the averaged fluid velocity and the speed of sound can be calculated. If a fluid is moving towards a transducer, the frequency of the returning signal will increase. As fluid moves away from a transducer, the frequency of the returning signal decrease. The frequency difference is equal to the reflected frequency minus the originating frequency and can be use to calculate the fluid flow speed.

[0044] A positive displacement flowmeter measures process fluid flow by precision-fitted rotors as flow measuring elements. Known and fixed volumes are displaced between the rotors. The rotation of the rotors are proportional to the volume of the fluid being displaced. The number of rotations of the rotor is counted by an integral electronic pulse transmitter and converted to volume and flow rate. The positive displacement rotor construction can be done in several ways: reciprocating piston meters (of single and multiple-piston types); and oval-gear meters having two rotating, oval-shaped gears with synchronized, close fitting teeth. With oval-gear meters, a fixed quantity of liquid passes through the meter for each revolution. Shaft rotation can be monitored to obtain specific flow rates.

[0045] With reference to FIG. 5, an operation of the ramping procedure is shown. The procedure starts at step 802 where the microwave ablation system is started. At step 804, t is set to t0 where t is time and t0 is the initial startup time. At step 806, a low energy level is outputted from the generator 28 to the antenna assembly 100. The sensor detects an operational parameter, such as temperature of the ablation probe, radiating behavior of the ablation probe, fluid pressure, forward and reflective power, fluid flow of coolant or insertion depth of probe, of the antenna assembly 100 as described above in step 808. In step 810, the detected operational parameter is compared to a predetermined range of values stored in the controller. The predetermined range of values may be set by a clinician or they may be stored in the controller by a manufacturer of the microwave ablation system. If the detected operational parameter is within the predetermined range, the procedure proceeds to step 812 where a determination is made as to whether t is less than t_RAMP. If t is less than t_RAMP, then the procedure proceeds to step 814 where t is increased in predetermined intervals. t can be increased in intervals of N seconds or N minutes where N is any positive integer. In step 816 the energy level output of the generator is increased and step 808, step 810 and step 812 are repeated. When t is no longer less than t_RAMP, the procedures proceeds to step 820 where the ablation procedure is started and used on a patient. If the controller makes a determination in step 810 that the detected operational parameter in step 808 is not within the predetermined range, the procedure proceeds to step 818 where the controller controls the generator to cease energy output.

[0046] The ramping procedure outlined above may avoid an assembly failure and potential clinician or patient injury. Although FIG. 5 depicts a particular arrangement of steps to perform the system check during a ramping procedure, it should be understood that a different arrangement of steps may be used while still falling under the scope of the present disclosure. During the ramping procedure and upon detection of abnormal sensor information, the power ramp would cease and return to zero. The ramp may be made long enough to reliably detect common malfunction mechanisms. Redundant circuit designs or redundant multiple sensor types may provide a form of sensor control.

[0047] For instance, if the cooling fluid pump is turned off and no fluid is in the antenna assembly, a pressure sensor may return abnormal pressure levels. As such, a power ramp would cease and the power does not reach a level where the coaxial cable would fail due to lack of cooling. If the antenna assembly is full of cooling fluid but the pump is not running, an abnormal reading from the pressure sensor or a rising temperature from a thermo probe would indicate that cooling of the probe is not sufficient most likely due to lack of flow. Therefore, the power ramp would cease and the power does not reach a level where the coaxial cable would fail due to lack of circulation.

[0048] In another example, if the device is not inserted into tissue resulting in a dangerous electromagnetic field pattern, a electromagnetic field detector such as the receiving antenna or rectenna would indicate abnormally high electromagnetic field levels along the shaft or around the handle of the antenna. The detection of the high electromagnetic field levels would prevent an unintended clinician or patient burn.

[0049] When the antenna assembly is subjected to high powers, defects may become readily apparent. On ramp up, the sensors indicate abnormal operating conditions thereby preventing the power level from reaching a level sufficient to cause device failure and avoiding clinician or patient injury.

[0050] Utilizing a test routine of the ablation probe which gradually subjects the device to increasing operational stresses while monitoring sensor status will allow for MWA systems to limit the number of devices which are damaged due to operator error, such as not turning on the cooling fluid pump. It will also reduce the likely hood likelihood of patient and/or user injury from potentially defective assemblies or from user error. This is especially important for high power microwave ablation devices, where failures may result in extremely high temperatures and flying debris.

[0051] The described embodiments of the present disclosure are intended to be illustrative rather than restrictive, and are not intended to represent every embodiment of the present disclosure. Various modifications and variations can be made without departing from the spirit or scope of the disclosure as set forth in the following claims both literally and in equivalents recognized in law.

Claims

What is claimed is:

1. A microwave ablation system, comprising:

a generator operable to output energy;

an ablation probe coupled to the generator, the ablation probe operable to deliver energy to tissue;

a controller operable to control the generator;

a coolant supply fluidly coupled to the ablation probe through a conduit; and

a flow rate monitor coupled to the conduit configured to monitor a flow rate of coolant flowing in the conduit, the flow rate monitor comprising at least one flow rate meter selected from the group consisting of an electric flow meter, a velocity flow meter, a calorimetric flow meter, an electromagnetic flow meter, an ultrasonic flow meter, and a positive displacement flow meter, wherein

the controller is programmed to perform a system check by ramping up energy output of the generator from a low energy level to a high energy level at a constant rate and monitoring an output from the flow rate monitor at predetermined intervals of time during the system check to determine the existence of an abnormal state, and wherein

the controller ceases energy output to the generator when the controller detects an abnormal state.

2. The microwave ablation system according to claim 1, further comprising at least one sensor coupled to the ablation probe and the controller, the at least one sensor operable to detect an operating parameter of the ablation probe.

3. The microwave ablation system according to claim 2, wherein the operational parameter is a temperature of the ablation probe.

4. The microwave ablation system according to claim 3, wherein the at least one sensor is a thermocouple, thermistor, or optical fiber.

5. The microwave ablation system according to claim 2, wherein the operational parameter is a radiating behavior.

6. The microwave ablation system according to claim 5, wherein the at least one sensor is a receiving antenna or rectenna.

7. The microwave ablation system according to claim 2, wherein the operational parameter is forward and/or reflected power.

8. The microwave ablation system according to claim 7, wherein the at least one sensor is a radio frequency power sensor.

9. The microwave ablation system according to claim 2, wherein the operational parameter is fluid pressure.

10. The microwave ablation system according to claim 9, wherein the at least one sensor is a pressure sensor.

Patent Citations (84)

Patent	Date	Inventor	Cited By
US5304214(A)	1994-04-01	DeFord et al.	Examiner
US5575789(A)	1996-11-01	Bell et al.	Examiner
US6002968(A)	1999-12-01	Edwards	Examiner
US7481809(B2)	2009-01-01	Stern et al.	Examiner
US2007/0050000(A1)	2007-03-01	Esch et al.	Examiner
US2007/0173805(A1)	2007-07-01	Weinberg et al.	Examiner
US2008/0077126(A1)	2008-03-01	Rashidi	Examiner
US2008/0300588(A1)	2008-12-01	Groth et al.	Applicant
US2009/0069799(A1)	2009-03-01	Daw et al.	Applicant
DE390937	1924-03-01		Applicant
DE1099658	1961-02-01		Applicant
DE1139927	1962-11-01		Applicant
DE1149832	1963-06-01		Applicant
DE1439302	1969-01-01		Applicant
DE2439587	1975-02-01		Applicant
DE2455174	1975-05-01		Applicant
DE2407559	1975-08-01		Applicant
DE2415263	1975-10-01		Applicant
DE2429021	1976-01-01		Applicant
DE2460481	1976-06-01		Applicant
DE2602517	1976-07-01		Applicant
DE2504280	1976-08-01		Applicant
DE2627679	1977-01-01		Applicant
DE2540968	1977-03-01		Applicant
DE2820908	1978-11-01		Applicant
DE2803275	1979-08-01		Applicant
DE2823291	1979-11-01		Applicant
DE2946728	1981-05-01		Applicant
DE3143421	1982-05-01		Applicant
DE3045996	1982-07-01		Applicant
DE3120102	1982-12-01		Applicant
DE3510586	1986-10-01		Applicant
DE3604823	1987-08-01		Applicant
DE8712328	1988-03-01		Applicant
DE3711511	1988-06-01		Applicant
DE3904558	1990-08-01		Applicant
DE3942998	1991-07-01		Applicant
DE4238263	1993-05-01		Applicant
DE4303882	1994-08-01		Applicant
DE4339049	1995-05-01		Applicant
DE29616210	1997-01-01		Applicant
DE19608716	1997-04-01		Applicant
DE19751106	1998-05-01		Applicant
DE19717411	1998-11-01		Applicant
DE19751108	1999-05-01		Applicant
DE19801173	1999-07-01		Applicant
DE19848540	2000-05-01		Applicant
DE10224154	2003-12-01		Applicant
DE10328514	2005-03-01		Applicant
DE102004022206	2005-12-01		Applicant
DE202005015147	2006-03-01		Applicant
EP246350	1987-11-01		Applicant
EP521264	1993-01-01		Applicant
EP556705	1993-08-01		Applicant
EP558429	1993-09-01		Applicant
EP836868	1998-04-01		Applicant
EP1159926	2001-05-01		Applicant
FR179607	1906-11-01		Applicant
FR1275415	1960-09-01		Applicant
FR1347865	1963-11-01		Applicant
FR2276027	1974-06-01		Applicant
FR2235669	1975-01-01		Applicant
FR2313708	1976-12-01		Applicant
FR2502935	1982-10-01		Applicant
FR2517953	1983-06-01		Applicant
FR2573301	1984-11-01		Applicant
FR2862813	2005-05-01		Applicant
FR2864439	2005-07-01		Applicant
JP5-5106	1993-01-01		Applicant
JP5-40112	1993-02-01		Applicant
JP6343644	1994-12-01		Applicant
JP7265328	1995-10-01		Applicant
JP8056955	1996-03-01		Applicant
JP8252263	1996-10-01		Applicant
JP9010223	1997-01-01		Applicant
JP11244298	1999-09-01		Applicant
JP2000342599	2000-12-01		Applicant
JP2000350732	2000-12-01		Applicant
JP2001008944	2001-01-01		Applicant
JP2001029356	2001-02-01		Applicant
JP2001128990	2001-05-01		Applicant
SU166452	1964-11-01		Applicant
SU401367	1974-11-01		Applicant
SU727201	1980-04-01		Applicant

Non-Patent Literature (279)

U.S. Appl. No. 12/129,482, filed May 29, 2008.Applicant
U.S. Appl. No. 12/135,425, filed Jun. 9, 2008.Applicant
U.S. Appl. No. 12/135,690, filed Jun. 9, 2008.Applicant
U.S. Appl. No. 12/147,093, filed Jun. 26, 2008.Applicant
U.S. Appl. No. 12/181,504, filed Jul. 29, 2008.Applicant
U.S. Appl. No. 12/184,556, filed Aug. 1, 2008.Applicant
U.S. Appl. No. 12/194,254, filed Aug. 19, 2008.Applicant
U.S. Appl. No. 12/197,601, filed Aug. 25, 2008.Applicant
U.S. Appl. No. 12/197,405, filed Aug. 25, 2008.Applicant
U.S. Appl. No. 12/197,473, filed Aug. 25, 2008.Applicant
U.S. Appl. No. 12/199,935, filed Aug. 28, 2008.Applicant
U.S. Appl. No. 12/203,474, filed Sep. 3, 2008.Applicant
U.S. Appl. No. 12/236,686, filed Sep. 24, 2008.Applicant
U.S. Appl. No. 12/244,850, filed Oct. 3, 2008.Applicant
U.S. Appl. No. 12/250,110, filed Oct. 13, 2008.Applicant
U.S. Appl. No. 12/250,171, filed Oct. 13, 2008.Applicant
U.S. Appl. No. 12/251,857, filed Oct. 15, 2008.Applicant
U.S. Appl. No. 12/253,457, filed Oct. 17, 2008.Applicant
U.S. Appl. No. 12/366,298, filed Feb. 5, 2009.Applicant
U.S. Appl. No. 12/389,906, filed Feb. 20, 2009.Applicant
U.S. Appl. No. 12/389,915, filed Feb. 20, 2009.Applicant
U.S. Appl. No. 12/401,268, filed Mar. 10, 2009.Applicant
U.S. Appl. No. 12/416,583, filed Apr. 1, 2009.Applicant
U.S. Appl. No. 12/419,395, filed Apr. 7, 2009.Applicant
U.S. Appl. No. 12/423,609, filed Apr. 14, 2009.Applicant
U.S. Appl. No. 12/434,903, filed May 4, 2009.Applicant
U.S. Appl. No. 12/436,237, filed May 6, 2009.Applicant
U.S. Appl. No. 12/436,239, filed May 6, 2009.Applicant
U.S. Appl. No. 12/436,231, filed May 6, 2009.Applicant
U.S. Appl. No. 12/472,831, filed May 27, 2009.Applicant
U.S. Appl. No. 12/475,082, filed May 29, 2009.Applicant
U.S. Appl. No. 12/476,960, filed Jun. 2, 2009.Applicant
U.S. Appl. No. 12/487,917, filed Jun. 19, 2009.Applicant
U.S. Appl. No. 12/493,302, filed Jun. 29, 2009.Applicant
U.S. Appl. No. 12/504,738, filed Jul. 17, 2009.Applicant
U.S. Appl. No. 12/508,700, filed Jul. 24, 2009.Applicant
U.S. Appl. No. 12/535,851, filed Aug. 5, 2009.Applicant
U.S. Appl. No. 12/535,856, filed Aug. 5, 2009.Applicant
U.S. Appl. No. 12/536,616, filed Aug. 6, 2009.Applicant
U.S. Appl. No. 12/542,348, filed Aug. 17, 2009.Applicant
U.S. Appl. No. 12/542,785, filed Aug. 18, 2009.Applicant
U.S. Appl. No. 12/547,155, filed Aug. 25, 2009.Applicant
U.S. Appl. No. 12/548,644, filed Aug. 27, 2009.Applicant
U.S. Appl. No. 12/555,576, filed Sep. 8, 2009.Applicant
U.S. Appl. No. 12/556,010, filed Sep. 9, 2009.Applicant
U.S. Appl. No. 12/561,096, filed Sep. 16, 2009.Applicant
U.S. Appl. No. 12/562,575, filed Sep. 18, 2009.Applicant
U.S. Appl. No. 12/562,842, filed Sep. 18, 2009.Applicant
U.S. Appl. No. 12/566,299, filed Sep. 24, 2009.Applicant
U.S. Appl. No. 12/568,067, filed Sep. 28, 2009.Applicant
U.S. Appl. No. 12/568,524, filed Sep. 28, 2009.Applicant
U.S. Appl. No. 12/568,551, filed Sep. 28, 2009.Applicant
U.S. Appl. No. 12/568,777, filed Sep. 29, 2009.Applicant
U.S. Appl. No. 12/568,838, filed Sep. 29, 2009.Applicant
U.S. Appl. No. 12/568,883, filed Sep. 29, 2009.Applicant
U.S. Appl. No. 12/568,972, filed Sep. 29, 2009.Applicant
U.S. Appl. No. 12/569,171, filed Sep. 29, 2009.Applicant
U.S. Appl. No. 12/582,857, filed Oct. 21, 2009.Applicant
U.S. Appl. No. 12/606,769, filed Oct. 27, 2009.Applicant
U.S. Appl. No. 12/607,221, filed Oct. 28, 2009.Applicant
U.S. Appl. No. 12/607,268, filed Oct. 28, 2009.Applicant
U.S. Appl. No. 12/619,462, filed Nov. 16, 2009.Applicant
U.S. Appl. No. 12/620,289, filed Nov. 17, 2009.Applicant
Alexander et al., “Magnetic Resonance Image-Directed Stereotactic Neurosurgery: Use of Image Fusion with Computerized Tomography to Enhance Spatial Accuracy” Journal Neurosurgery, 83 (1995), pp. 271-276.Applicant
Anderson et al., “A Numerical Study of Rapid Heating for High Temperature Radio Frequency Hyperthermia” International Journal of Bio-Medical Computing, 35 (1994), pp. 297-307.Applicant
Anonymous. (1999) Auto Suture MIBB Site Marker: Single Use Clip Applier, United States Surgical (Product instructions), 2 pages.Applicant
Anonymous. (2001) Disposable Chiba Biopsy Needles and Trays, Biopsy and Special Purpose Needles Cook Diagnostic and Interventional Products Catalog (products list), 4 pages.Applicant
Anonymous. (1987) Homer Mammalok™ Breast Lesion Needle/Wire Localizer, Namic® Angiographic Systems Division, Glens Falls, New York, (Hospital products price list), 4 pages.Applicant
Anonymous. (1999) MIBB Site Marker, United States Surgical (Sales brochure), 4 pages.Applicant
Anonymous. Blunt Tubes with Finished Ends. Pointed Cannula, Popper & Sons Biomedical Instrument Division, (Products Price List), one page, Jul. 19, 2000.Applicant
Anonymous. Ground Cannulae, ISPG, New Milford, CT, (Advertisement) one page, Jul. 19, 2000.Applicant
B. Levy M.D. et al., “Randomized Trial of Suture Versus Electrosurgical Bipolar Vessel Sealing in Vaginal Hysterectomy” Obstetrics & Gynecology, vol. 102, No. 1, Jul. 2003.Applicant
B. Levy M.D. et al., “Update on Hysterectomy New Technologies and Techniques” OBG Management, Feb. 2003.Applicant
B. Levy M.D., “Use of a New Vessel Ligation Device During Vaginal Hysterectomy” FIGO 2000, Washington, D.C.Applicant
B. F. Mullan et al., (May 1999) “Lung Nodules: Improved Wire for CT-Guided Localization,” Radiology 211:561-565.Applicant
B. T. Heniford M.D. et al., “Initial Research and Clinical Results with an Electrothermal Bipolar Vessel Sealer” Oct. 1999.Applicant
Bergdahl et al., “Studies on Coagulation and the Development of an Automatic Computerized Bipolar Coagulator” Joumal of Neurosurgery 75:1 (Jul. 1991). pp. 148-151.Applicant
Bulletin of the American Physical Society. vol. 47, No. 5, Aug. 2002, p. 41.Applicant
C. F. Gottlieb et al., “Interstitial Microwave Hyperthermia Applicators having Submillimetre Diameters”, Int. J. Hyperthermia, vol. 6, No. 3, pp. 707-714. 1990.Applicant
C. H. Durney et al., “Antennas for Medical Applications”, Antenna Handbook: Theory Application and Design, p. 24-40, Van Nostrand Reinhold, 1988 New York, V.T. Lo, S.W. Lee.Applicant
Carbonell et al., “Comparison of the Gyrus PlasmaKinetic Sealer and the Valleylab LigaSure™ Device in the Hemostasis of Small, Medium, and Large-Sized Arteries” Carolinas Laparoscopic and Advanced Surgery Program, Carolinas Medical Center, Charlotte, NC 2003.Applicant
Carus et al., “Initial Experience With the LigaSure™ Vessel Sealing System in Abdominal Surgery” Innovations That Work, Jun. 2002.Applicant
Chicharo et al., “A Sliding Goertzel Algorithm” Aug. 1996 DOS pp. 283-297 Signal Processing, Elsevier Science Publishers B.V. Amsterdam, NL, vol. 52, No. 3.Applicant
Chou, C.K., (1995) “Radiofrequency Hyperthermia in Cancer Therapy,” Chapter 941n Biologic Effects of Nonionizing Electromagnetic Fields, CRC Press, Inc., pp. 1424-1428.Applicant
Chung et al., “Clinical Experience of Sutureless Closed Hemorrhoidectomy with LigaSure™” Diseases of the Colon & Rectum, vol. 46, No. 1. Jan. 2003.Applicant
Cosman et al., “Methods of Making Nervous System Lesions” In William RH, Rengachary SS (eds): Neurosurgery, New York: McGraw-Hill, vol. 111, (1984), pp. 2490-2499.Applicant
Cosman et al., “Radiofrequency Lesion Generation and its Effect on Tissue Impedence”, Applied Neurophysiology, 51:230-242, 1988.Applicant
Cosman et al., “Theoretical Aspects of Radiofrequency Lesions in the Dorsal Root Entry Zone” Neurosurgery 15:(1984), pp. 945-950.Applicant
Crawford et al., “Use of the LigaSure™ Vessel Sealing System in Urologic Cancer Surger” Grand Rounds in Urology 1999, vol. 1, Issue 4, pp. 10-17.Applicant
Dulemba et al., “Use of a Bipolar Electrothermal Vessel Sealer in Laparoscopically Assisted Vaginal Hysterectomy” Sales/Product Literature; Jan. 2004.Applicant
E. David Crawford, “Evaluation of a New Vessel Sealing Device in Urologic Cancer Surgery” Sales/Product Literature 2000.Applicant
E. David Crawford, “Use of a Novel Vessel Sealing Technology in Management of the Dorsal Veinous Complex” Sales/Product Literature 2000.Applicant
Esterline, “Light Key Projection Keyboard” 2004 Advanced Input Systems, located at: <http://www.advanced-input.com/lightkey> last visited on Feb. 10, 2005.Applicant
Esterline Product Literature, “Light Key: Visualize a Virtual Keyboard. One With No Moving Parts”, Nov. 1, 2003; 4 pages.Applicant
Geddes et al., “The Measurement of Physiologic Events by Electrical Impedence” Am. J. MI, Jan. Mar. 1964, pp. 16-27.Applicant
Goldberg et al., “Image-guided Radiofrequency Tumor Ablation: Challenges and Opportunities—Part I”, (2001) J Vasc. Interv. Radiol, vol. 12, pp. 1021-1032.Applicant
Goldberg et al., “Tissue Ablation with Radiofrequency: Effect of Probe Size, Gauge, Duration, and Temperature on Lesion Volume” Acad Radio (1995) vol. 2, No. 5, pp. 399-404.Applicant
H. Schwarzmaier et al., “Magnetic Resonance Imaging of Microwave Induced Tissue Heating” Dept. of Laser Medicine & Dept. of Diagnostic Radiology; Heinrich-Heine-University, Duesseldorf, Germany; Dec. 8, 1994; pp. 729-731.Applicant
Heniford et al., “Initial Results with an Electrothermal Bipolar Vessel Sealer” Surgical Endoscopy (2001) 15:799-801.Applicant
Herman at al,, “Laparoscopic Intestinal Resection With the LigaSure™ Vessel Sealing System: A Case Report” Innovations That Work, Feb. 2002.Applicant
Humphries Jr. et al., “Finite•Element Codes to Model Electrical Heating and Non•Llnear Thermal Transport in Biological Media”, Proc. ASME HTD-355, 131 (1997).Applicant
Ian D. McRury et al., The Effect of Ablation Sequence and Duration on Lesion Shape Using Rapidly Pulsed Radiofrequency Energy Through Electrodes, Feb. 2000, Springer Netherlands, vol. 4; No. 1, pp. 307-320.Applicant
Jarrett et al., “Use of the LigaSure™ Vessel Sealing System for Peri-Hilar Vessels in Laparoscopic Nephrectomy” Sales/Product Literature 2000.Applicant
Johnson et al., “Evaluation of a Bipolar Electrothermal Vessel Sealing Device in Hemorrhoidectomy” Sales/Product Literature, Jan. 2004.Applicant
Johnson, “Evaluation of the LigaSure™ Vessel Sealing System in Hemorrhoidectormy” American College of Surgeons (ACS) Clinic La Congress Poster (2000).Applicant
Johnson, “Use of the LigaSure™ Vessel Sealing System in Bloodless Hemorrhoidectomy” Innovations That Work, Mar. 2000.Applicant
Joseph G. Andriole M.D. et al., “Biopsy Needle Characteristics Assessed in the Laboratory”, Radiology 148: 659-662, Sep. 1983.Applicant
Joseph Ortenberg, “LigaSure™ System Used in Laparoscopic 1st and 2nd Stage Orchiopexy” Innovations That Work, Nov. 2002.Applicant
Kennedy et al., “High-burst-strength, feedback-controlled bipolar vessel sealing” Surgical Endoscopy (1998) 12: 876-878.Applicant
Kopans, D.B. et al., (Nov. 1985) “Spring Hookwire Breast Lesion Localizer: Use with Rigid-Compression. Mammographic Systems,” Radiology 157(2):537-538.Applicant
Koyle et al., “Laparoscopic Palomo Varicocele Ligation in Children and Adolescents” Pediatric Endosurgery & Innovative Techniques, vol. 6, No. 1, 2002.Applicant
LigaSure™ Vessel Sealing System, the Seal of Confidence in General , Gynecologic, Urologic, and Laparaoscopic Surgery, Sales/Product Literature, Jan. 2004.Applicant
Livraghi et al., (1995) “Saline-enhanced RF Tissue Ablation in the Treatment of Liver Metastases”, Radiology, pp. 205-210, Abstract only.Applicant
Lyndon B. Johnson Space Center, Houston, Texas, “Compact Directional Microwave Antenna for Localized Heating,” NASA Tech Briefs. Mar. 2008.Applicant
M. A. Astrahan, “A Localized Current Field Hyperthermia System for Use with 192-Iridium Interstitial Implants” Medical Physics. 9(3), May/Jun. 1982.Applicant
Magdy F. Iskander et al., “Design Optimization of Interstitial Antennas”, IEEE Transactions on Biomedical Engineering, vol. 36, No. 2, Feb. 1989, pp. 238-246.Applicant
McGahan et al., (1995) “Percutaneous Ultrasound-guided Radiofrequency Electrocautery Ablation of Prostate Tissue in Dogs”, Acad Radiol, vol. 2, No. 1: pp. 61-65.Applicant
McLellan et al., “Vessel Sealing for Hemostasis During Pelvic Surgery” Int'l Federation of Gynecology and Obstetrics FIGO World Congress 2000, Washington, DC.Applicant
MDTECH product literature (Dec. 1999) “FlexStrand”: product description, 1 page.Applicant
MDTECH product literature (Mar. 2000) I'D Wire: product description, 1 page.Applicant
Medtrex Brochure “The O.R. Pro 300” 1 page, Sep. 1998.Applicant
Michael Choti. “Abdominoperineal Resection with the LigaSure™ Vessel Sealing System and LigaSure™ Atlas 20 cm Open Instrument” Innovations That Work. Jun. 2003.Applicant
Muller et al., “Extended Left Hemicolectomy Using the LigaSure™ Vessel Sealing System” Innovations That Work. LJ, Sep. 1999.Applicant
Murakami, R. et al., (1995). “Treatment of Hepatocellular Carcinoma: Value of Percutaneous Microwave Coagulation,” American Journal of Radiology (AJR) 164:1159-1164.Applicant
Ni Wei et al., “A Signal Processing Method for the Coriolis Mass Flowmeter Based on a Normalized . . . ” Journal of Applied Sciences.Yingyong Kexue Xuebao, Shanha CN, vol. 23, No. 2:(Mar. 2005); pp. 160-184, Abstract only.Applicant
Ogden, “Goertzel Alternative to the Fourier Transform” Jun. 1993 pp. 485-487 Electronics World; Reed Business Publishing, Sutton, Surrey, BG, vol. 99, No. 9, 1687.Applicant
Olsson M.D. et al., “Radical Cystectomy in Females” Current Surgical Techniques in Urology, vol. 14, Issue 3, 2001.Applicant
Organ, L W., “Electrophysiologic Principles of Radiofrequency Lesion Making” Appl. Neurophysiol, vol. 39: pp. 69-76 (1976/77).Applicant
P.R. Stauffer et al., “Interstitial Heating Technologies”, Thermoradiotheray and Thermochemotherapy (1995) vol. I, Biology, Physiology, Physics, pp. 279-320.Applicant
Palazzo et al., “Randomized clinical trial of LigaSure™ versus open haemorrhoidectomy” British Journal of Surgery 2002,89,154-157 “Innovations in Electrosurgery” Sales/Product Literature; Dec. 31, 2000.Applicant
Paul G. Horgan, “A Novel Technique for Parenchymal Division During Hepatectomy” The American Journal of Surgery, vol. 181, No. 3, Apr. 2001, pp. 236-237.Applicant
Peterson et al., “Comparison of Healing Process Following Ligation with Sutures and Bipolar Vessel Sealing” Surgical Technology International (2001).Applicant
R. Gennari et al., (Jun. 2000) “Use of Technetium-99m-Labeled Colloid Albumin for Preoperative and Intraoperative Localization of Non palpable Breast Lesions,” American College of Surgeons. 190(6):692-699.Applicant
Valleylab Brochure, “Reducing Needlestick Injuries in the Operating Room” 1 page, Mar. 2001.Applicant
Reidenbach, (1995) “First Experimental Results with Special Applicators for High-Frequency Interstitial Thermotherapy”, Society Minimally Invasive Therapy, 4(Suppl 1):40 (Abstr).Applicant
Richard Wolf Medical Instruments Corp. Brochure, “Kleppinger Bipolar Forceps & Bipolar Generator” 3 pages, Jan. 1989.Applicant
Rothenberg et al., “Use of the LigaSure™ Vessel Sealing System in Minimally Invasive Surgery in Children” Int'l Pediatric Endosurgery Group (I PEG) 2000.Applicant
Sayfan et al., “Sutureless Closed Hemorrhoidectomy: A New Technique” Annals of Surgery, vol. 234. No. 1. Jul. 2001, pp. 21-24.Applicant
Sengupta et al., “Use of a Computer-Controlled Bipolar Diathermy System in Radical Prostatectomies and Other Open Urological Surgery” ANZ Journal of Surgery (2001) 71.9 pp. 538-540.Applicant
Sigel et al., “The Mechanism of Blood Vessel Closure by High Frequency Electrocoagulation” Surgery Gynecology & Obstetrics, Oct. 1965 pp. 823-831.Applicant
Solbiati et al., (2001) “Percutaneous Radio-frequency Ablation of Hepatic Metastases from Colorectal Cancer: Long-term Results in 117 Patients”, Radiology, vol. 221, pp. 159-166.Applicant
Strasberg et al., “Use of a Bipolar Vassel-Sealing Device for Parenchymal Transection During Liver Surgery” Journal of Gastrointestinal Surgery, vol. 6, No. 4, Jul./Aug. 2002 pp. 569-574.Applicant
Sugita et al., “Bipolar Coagulator with Automatic Thermocontrol” J. Neurosurg., vol. 41, Dec. 1944, pp. 777-779.Applicant
Sylvain Labonte et al., “Monopole Antennas for Microwave Catheter Ablation”, IEEE Trans. on Microwave Theory and Techniques, vol. 44, No. 10, pp. 1832-1840, Oct. 1995.Applicant
T. Matsukawa et al., “Percutaneous Microwave Coagulation Therapy in Liver Tumors”, Acta Radiologica, vol. 38, pp. 410-415, 1997.Applicant
T. Seki et al., (1994) “Ultrasonically Guided Percutaneous Microwave Coagulation Therapy for Small Hepatocellular Carcinoma,” Cancer 74(3):817-825.Applicant
Urologix, Inc.—Medical Professionals: Targis™ Technology (Date Unknown). “Overcoming the Challenge” located at: <http://www.urologix.com!medicaUtechnology.html > last visited on Apr. 27, 2001. 3 pages.Applicant
Urrutia et al., (1988). “Retractable-Barb Needle for Breast Lesion Localization: Use in 60 Cases,” Radiology 169(3):845-847.Applicant
Valleylab Brochure, “Valleylab Electroshield Monitoring System” 2 pages, Nov. 1995.Applicant
ValleyLab Brochure, “Electosurgery: A Historical Overview”, Innovations in Electrosurgery, 1999.Applicant
Vallfors et al., “Automatically Controlled Bipolar Electrocoagulation—‘COA-COMP’” Neurosurgical Review 7:2-3 (1984) pp. 187-190.Applicant
W. Scott Helton, “LigaSure™ Vessel Sealing System: Revolutionary Hemostasis Product for General Surgery” Sales/Product Literature 1999.Applicant
Wald et al., “Accidental Burns”, JAMA, Aug. 16, 1971, vol. 217, No. 7, pp. 916-921.Applicant
Walt Boyles, “Instrumentation Reference Book”, 2002, Butterworth-Heinemann, pp. 262-264.Applicant
European Search Report EP 98300964.8 dated Dec. 13, 2000.Applicant
European Search Report EP 98944778 dated Nov. 7, 2000.Applicant
European Search Report EP 98958575.7 dated Oct. 29, 2002.Applicant
European Search Report EP 03721482 dated Feb. 6, 2006.Applicant
European Search Report EP 04009964 dated Jul. 28, 2004.Applicant
European Search Report EP 04013772 dated Apr. 11, 2005.Applicant
European Search Report EP 04015980 dated Nov. 3, 2004.Applicant
European Search Report EP 04015981.6 dated Oct. 25, 2004.Applicant
European Search Report EP 04027314 dated Mar. 31, 2005.Applicant
European Search Report EP 04027479 dated Mar. 17, 2005.Applicant
European Search Report EP 04027705 dated Feb. 10, 2005.Applicant
European Search Report EP 04710258 dated Oct. 15, 2004.Applicant
European Search Report EP 04752343.6 dated Jul. 31, 2007.Applicant
European Search Report EP 04778192.7 dated Jul. 1, 2009.Applicant
European Search Report EP 05002027.0 dated May 12, 2005.Applicant
European Search Report EP 05002769.7 dated Jun. 19, 2006.Applicant
European Search Report EP 05013463.4 dated Oct. 7, 2005.Applicant
European Search Report EP 05013895 dated Oct. 21, 2005.Applicant
European Search Report EP 05014156.3 dated Jan. 4, 2006.Applicant
European Search Report EP 05016399 dated Jan. 13, 2006.Applicant
European Search Report EP 05017281 dated Nov. 24, 2005.Applicant
European Search Report EP 05019130.3 dated Oct. 27, 2005.Applicant
European Search Report EP 05019882 dated Feb. 16, 2006.Applicant
European Search Report EP 05020665.5 dated Feb. 27, 2006.Applicant
European Search Report EP 05020666.3 dated Feb. 27, 2006.Applicant
European Search Report EP 05021025.1 dated Mar. 13, 2006.Applicant
European Search Report EP 05021197.8 dated Feb. 20, 2006.Applicant
European Search Report EP 05021777 dated Feb. 23, 2006.Applicant
European Search Report EP 05021779.3 dated Feb. 2, 2006.Applicant
European Search Report EP 05021780.1 dated Feb. 23, 2006.Applicant
European Search Report EP 05021935 dated Jan. 27, 2006.Applicant
European Search Report EP 05021936.9 dated Feb. 6, 2006.Applicant
European Search Report EP 05021937.7 dated Jan. 23, 2006.Applicant
European Search Report EP 05021939 dated Jan. 27, 2006.Applicant
European Search Report EP 05021944.3 dated Jan. 25, 2006.Applicant
European Search Report EP 05022350.2 dated Jan. 30, 2006.Applicant
European Search Report EP 05023017.6 dated Feb. 24, 2006.Applicant
European Search Report EP 05025423.4 dated Jan. 19, 2007.Applicant
European Search Report EP 05025424 dated Jan. 30, 2007.Applicant
European Search Report EP 05810523 dated Jan. 29, 2009.Applicant
European Search Report EP 06000708.5 dated May 15, 2006.Applicant
European Search Report EP 06002279.5 dated Mar. 30, 2006.Applicant
European Search Report EP 06005185.1 dated May 10, 2006.Applicant
European Search Report EP 06005540 dated Sep. 24, 2007.Applicant
European Search Report EP 06006717.0 dated Aug. 11, 2006.Applicant
European Search Report EP 06006961 dated Oct. 22, 2007.Applicant
European Search Report EP 06006963 dated Jul. 25, 2006.Applicant
European Search Report EP 06008779.8 dated Jul. 13, 2006.Applicant
European Search Report EP 06009435 dated Jul. 13, 2006.Applicant
European Search Report EP 06010499.9 dated Jan. 29, 2008.Applicant
European Search Report EP 06014461.5 dated Oct. 31, 2006.Applicant
European Search Report EP 06018206.0 dated Oct. 20, 2006.Applicant
European Search Report EP 06019768 dated Jan. 17, 2007.Applicant
European Search Report EP 06020574.7 dated Oct. 2, 2007.Applicant
European Search Report EP 06020583.8 dated Feb. 7, 2007.Applicant
European Search Report EP 06020584.6 dated Feb. 1, 2007.Applicant
European Search Report EP 06020756.0 dated Feb. 16, 2007.Applicant
European Search Report EP 06022028.2 dated Feb. 13, 2007.Applicant
European Search Report EP 06023756.7 dated Feb. 21, 2008.Applicant
European Search Report EP 06024122.1 dated Apr. 16, 2007.Applicant
European Search Report EP 06024123.9 dated Mar. 6, 2007.Applicant
European Search Report EP 06025700.3 dated Apr. 12, 2007.Applicant
European Search Report EP 07000885.9 dated May 15, 2007.Applicant
European Search Report EP 07001480.8 dated Apr. 19, 2007.Applicant
European Search Report EP 07001481.6 dated May 2, 2007.Applicant
European Search Report EP 07001485.7 dated May 23, 2007.Applicant
European Search Report EP 07001488.1 dated Jun. 5, 2007.Applicant
European Search Report EP 07001489.9 dated Dec. 20, 2007.Applicant
European Search Report EP 07001491 dated Jun. 6, 2007.Applicant
European Search Report EP 07001527.6 dated May 18, 2007.Applicant
European Search Report EP 07007783.9 dated Aug. 14, 2007.Applicant
European Search Report EP 07008207.8 dated Sep. 13, 2007.Applicant
European Search Report EP 07009026.1 dated Oct. 8, 2007.Applicant
European Search Report EP 07009028 dated Jul. 16, 2007.Applicant
European Search Report EP 07009029.5 dated Jul. 20, 2007.Applicant
European Search Report EP 07009321.6 dated Aug. 28, 2007.Applicant
European Search Report EP 07009322.4 dated Jan. 14, 2008.Applicant
European Search Report EP 07010672.9 dated Oct. 16, 2007.Applicant
European Search Report EP 07010673.7 dated Oct. 5, 2007.Applicant
European Search Report EP 07013779.9 dated Oct. 26, 2007.Applicant
European Search Report EP 07015191.5 dated Jan. 23, 2007.Applicant
European Search Report EP 07015601.3 dated Jan. 4, 2007.Applicant
European Search Report EP 07015602.1 dated Dec. 20, 2007.Applicant
European Search Report EP 07018375.1 dated Jan. 8, 2008.Applicant
European Search Report EP 07018821 dated Jan. 14, 2008.Applicant
European Search Report EP 07019173.9 dated Feb. 12, 2008.Applicant
European Search Report EP 07019174.7 dated Jan. 29, 2008.Applicant
European Search Report EP 07019178.8 dated Feb. 12, 2008.Applicant
European Search Report EP 07020283.3 dated Feb. 5, 2008.Applicant
European Search Report EP 07253835.8 dated Dec. 20, 2007.Applicant
European Search Report EP 08001019 dated Sep. 23, 2008.Applicant
European Search Report EP 08004975 dated Jul. 24, 2008.Applicant
European Search Report EP 08006731.7 dated Jul. 29, 2008.Applicant
European Search Report EP 08006733 dated Jul. 7, 2008.Applicant
European Search Report EP 08006734.1 dated Aug. 18, 2008.Applicant
European Search Report EP 08006735.8 dated Jan. 8, 2009.Applicant
European Search Report EP 08011282 dated Aug. 14, 2009.Applicant
European Search Report EP 08011705 dated Aug. 20, 2009.Applicant
European Search Report EP 08012829.1 dated Oct. 29, 2008.Applicant
European Search Report EP 08015842 dated Dec. 5, 2008.Applicant
European Search Report EP 08019920.1 dated Mar. 27, 2009.Applicant
European Search Report EP 08169973.8 dated Apr. 6, 2009.Applicant
European Search Report EP 09156861.8 dated Aug. 4, 2009.Applicant
European Search Report EP 09161502.1 dated Sep. 2, 2009.Applicant
European Search Report EP 09166708 dated Oct. 15, 2009.Applicant
International Search Report PCT/US98/18640 dated Jan. 29, 1998.Applicant
International Search Report PCT/US98/23950 dated Jan. 14, 1998.Applicant
International Search Report PCT/US99/24869 dated Feb. 11, 2000.Applicant
International Search Report PCT/US01/11218 dated Aug. 14, 2001.Applicant
International Search Report PCT/US01/11224 dated Nov. 13, 2001.Applicant
International Search Report PCT/US01/11340 dated Aug. 16, 2001.Applicant
International Search Report PCT/US01/11420 dated Oct. 16, 2001.Applicant
International Search Report PCT/US02/01890 dated Jul. 25, 2002.Applicant
International Search Report PCT/US02/11100 dated Jul. 16, 2002.Applicant
International Search Report PCT/US03/09483 dated Aug. 13, 2003.Applicant
International Search Report PCT/US03/22900 dated Dec. 2, 2003.Applicant
International Search Report PCT/US03/37110 dated Jul. 25, 2005.Applicant
International Search Report PCT/US03/37111 dated Jul. 28, 2004.Applicant
International Search Report PCT/US03/37310 dated Aug. 13, 2004.Applicant
International Search Report PCT/US04/04685 dated Aug. 27, 2004.Applicant
International Search Report PCT/US04/13273 dated Dec. 15, 2004.Applicant
International Search Report PCT/US04/15311 dated Jan. 12, 2004.Applicant
International Search Report PCT/US05/36168 dated Aug. 28, 2006.Applicant
International Search Report PCT/US08/052460 dated Apr. 24, 2008.Applicant
International Search Report PCT/US09/31658 dated Mar. 11, 2009.Applicant

Abstract